Andrew Regan
Direktor/Vorstandsmitglied bei CONDUIT PHARMACEUTICALS INC.
Vermögen: 206 615 $ am 30.04.2024
Profil
Andrew Regan is the founder of Conduit Pharmaceuticals Ltd.
(founded in 2019) and Corvus Capital Ltd.
(founded in 2008), where he held the title of Chief Executive Officer.
He is currently the Chief Executive Officer of Corvus Capital, Inc. since 2004 and a Director at Conduit Pharmaceuticals, Inc. since 2023.
Dr. Regan obtained a doctorate degree from Oxford Brookes University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.05.2024 | 66 650 ( 0,09% ) | 206 615 $ | 30.04.2024 |
Aktive Positionen von Andrew Regan
Unternehmen | Position | Beginn |
---|---|---|
CONDUIT PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 22.09.2023 |
Corvus Capital, Inc.
Corvus Capital, Inc. Financial ConglomeratesFinance Corvus Capital, Inc. provides investment and asset management services. Its services include corporate development, investment accounting, corporate legal counseling, and equity capital market research services. The company is headquartered in Road Town, British Virgin Islands. | Vorstandsvorsitzender | 01.09.2004 |
Corvus Capital Ltd.
Corvus Capital Ltd. Financial ConglomeratesFinance Corvus Capital Ltd. operates as an investment and South African management company. The private company is based in Johannesburg, South Africa and has subsidiaries in the UK and the Cayman Islands. The company was founded by Andrew Regan, who has been the CEO since incorporation. | Vorstandsvorsitzender | 01.01.2008 |
Ehemalige bekannte Positionen von Andrew Regan
Unternehmen | Position | Ende |
---|---|---|
Conduit Pharmaceuticals Ltd.
Conduit Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Conduit Pharmaceuticals Ltd. is a Caymanian clinical stage biopharmaceutical company. The private company is based in George Town, Cayman Islands. The company was founded in 2019. The CEO is David Joszef Tapolczay. | Gründer | - |
Ausbildung von Andrew Regan
Oxford Brookes University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CONDUIT PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Corvus Capital, Inc.
Corvus Capital, Inc. Financial ConglomeratesFinance Corvus Capital, Inc. provides investment and asset management services. Its services include corporate development, investment accounting, corporate legal counseling, and equity capital market research services. The company is headquartered in Road Town, British Virgin Islands. | Finance |
Corvus Capital Ltd.
Corvus Capital Ltd. Financial ConglomeratesFinance Corvus Capital Ltd. operates as an investment and South African management company. The private company is based in Johannesburg, South Africa and has subsidiaries in the UK and the Cayman Islands. The company was founded by Andrew Regan, who has been the CEO since incorporation. | Finance |
Conduit Pharmaceuticals Ltd.
Conduit Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Conduit Pharmaceuticals Ltd. is a Caymanian clinical stage biopharmaceutical company. The private company is based in George Town, Cayman Islands. The company was founded in 2019. The CEO is David Joszef Tapolczay. | Health Technology |